Enjoy complimentary customisation on priority with our Enterprise License!
The Heart Transplantation Therapeutics Market size is forecast to increase by USD 135.37 million, at a CAGR of 3.24% between 2023 and 2028.
The global heart transplantation therapeutics market has various novel and generic drugs that are available in different dosage forms. In addition, these dosage forms primarily comprise extended- and delayed-release tablets and capsules, dispersible granules for oral suspension, and powder for injection. Moreover, such multiple dosage forms of medicine are made available to improve adoption among patients, even if they contain large amounts of active pharmaceutical ingredients (APIs). Hence, such factors are positively impacting the market.
Technavio has segmented the market into Drug Class, Distribution Channel, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 - 2022, besides analyzing the current market scenario.
To learn more about this report, Download Report Sample
The immunosuppressants segment is estimated to witness significant growth during the forecast period. Immunosuppressants segment can be referred to as drugs that are used to suppress the body's immune response. In addition, these drugs include immunosuppressive drugs and environmental toxins. Furthermore, immunosuppressants find their use in patients undergoing organ transplantation. If a new organ is donated by an identical twin, the recipient may not have to take these medications.
Get a glance at the market contribution of various segments Download PDF Sample
The immunosuppressants segment was the largest segment and was valued at USD 530.29 million in 2018. Moreover, when a patient undergoes organ transplantation, the new organ appears as a foreign agent in the body's defense system, which triggers a natural immune response against the entry of the transplanted organ. In addition, the body's defense system prepares the body to attack the transplanted organ and try to damage or destroy it. Therefore, immunosuppressants are used to offset this impact. Furthermore, these drugs suppress the body's ability to attack the newly transplanted organ and aid in keeping it healthy and free from damage. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
Hospital pharmacies segment play a major role as a significant market segment within the global heart transplantation therapeutics market, acting as a crucial distribution channel for these specialized medications. In addition, one of the main reasons why hospital pharmacies distinguish themselves as a separate market segment is because they operate in close proximity to healthcare facilities and transplantation centers. Moreover, hospital pharmacies operate on the hospital's premises, which allows for efficient coordination among healthcare professionals involved with heart transplantation and the acquisition of critical therapeutics. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
The retail pharmacies segment is a vital link between drug companies and patients. In addition, they are often located in local communities and provide a convenient and easy-to-use point of access for patients looking to obtain prescription medications associated with heart transplantation therapies. Moreover, one of the biggest advantages of retail pharmacies within the global heart transplantation therapeutics market is their widespread presence. Furthermore, retail pharmacies are strategically located in both urban and suburban settings, ensuring that patients from all over the country have access to life-saving drugs. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 35% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. The market growth in North America is fuelled by the sales of immunosuppressants and the increasing prevalence of various associated risk factors for heart transplantation in the region. In addition, the US was the largest revenue contributor to the market in the region. Moreover, the high market share of the US is attributed to the rising number of organ transplantation procedures, including heart transplantation, in the country and the availability of advanced healthcare infrastructure, which ensures the continuous supply of therapeutics to patients undergoing heart transplantation. In addition, the prevalence of cardiovascular diseases is also rising in the region. Hence, such factors are driving the market growth in North America during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
AbbVie Inc: The company offers heart transplantation therapeutics such as Gengraf which is used to help prevent organ rejection in people who have received heart transplants.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
One of the key factors driving the heart transplantation therapeutics market growth is the high dependency on immunosuppressants for heart transplantation. Several advances have been made in surgical techniques across the world, especially in organ transplants. Therefore, such advances are increasing the demand for organ transplantations, including heart transplantation. Furthermore, graft rejection is one of the major challenges associated with organ transplantation, which is further intensified in heart transplantation.
Moreover, many research studies have proved that after the introduction of immunosuppressive drugs in the management of post-heart transplant patients, the incidence of rejection decreased significantly. In addition, this further results in the improvement in mortality and long-term outcomes. Furthermore, the immunosuppressants intended for maintenance regimens are used throughout the patient's life to prevent both acute and chronic rejection. Hence, such factors are driving the market growth during the forecast period.
A key factor shaping the heart transplantation therapeutics market growth is the advent of techniques for heart transplantation. Organ transplantation is one of the foremost emerging fields in the modern medical therapy area and several patients across the world have undergone the transplantation of various organs. In addition, the transplantation of organs such as lungs, pancreas, and intestines is also occurring.
Moreover, revolutionary achievements in the field of regenerative therapies have generated interest among researchers, and they are discovering possible regenerative medicinal applications in organ transplantation, including heart transplantation. In addition, several novel technologies, including stem cells and tissue engineering, have proved to have the potential to enhance organ functions or repair damaged organs. Hence, such factors are driving the market growth during the forecast period.
Adverse effects of immunosuppressants are one of the key challenges hindering the heart transplantation therapeutics market growth. The global heart transplantation therapeutics market has different immunosuppressants that are utilized for the prevention and treatment of the symptoms caused by heart transplantation. In addition, immunosuppressants are drugs that reduce the immune system's response in rejecting a transplanted organ.
Moreover, these drugs are highly effective in reducing the risk of organ rejection; however, they are associated with several side effects. In addition, even though the side effects of immunosuppressants are often mild, they last for a long time. Therefore, these side effects significantly impact patient adherence to the treatment using immunosuppressive drugs. Hence, such factors are hindering the market growth during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Heart Transplantation Therapeutics Market Customer Landscape
The heart transplantation therapeutics market report forecasts market growth by revenue at global, regional & country levels and provides a market growth analysis of the latest market trends and analysis trends and growth opportunities from 2018 to 2028.
Heart Transplantation Therapeutics Market Scope |
|
Report Coverage |
Details |
Page number |
172 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 3.24% |
Market Growth 2024-2028 |
USD 135.37 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
2.76 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
North America at 35% |
Key countries |
US, Germany, UK, France, and Japan |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
AbbVie Inc., Astellas Pharma Inc., Biocon Ltd., Dr Reddys Laboratories Ltd., Endo International Plc, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Jubilant Pharmova Ltd., LEO Pharma AS, Lupin Ltd., McKesson Corp., Novartis AG, Pfizer Inc., RPG Enterprises, Strides Pharma Science Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., F. Hoffmann La Roche Ltd., and Panacea Biotec Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Drug Class
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.